Form 4: Zoetis EVP Acquires Phantom Stock Units

Zoetis Executive Vice President Julie Fuller acquired 669.3367 phantom stock units through the company's Supplemental Savings Plan.

Summary

• Julie Fuller, Executive Vice President of Zoetis Inc., acquired 669.3367 phantom stock units on March 27, 2026.
• These units were obtained through the Zoetis Supplemental Savings Plan.
• Each phantom stock unit's value is determined by reference to the market value of Zoetis common stock and approximately 5% cash-equivalent investments.
• The units are settled in cash upon the reporting person's separation from service.
• Following this transaction, Julie Fuller beneficially owns a total of 1,247.3931 phantom stock units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating executive alignment with shareholder interests through a standard compensation mechanism, without any negative implications or unexpected events.

Positives

• An executive acquiring phantom stock units aligns their interests with shareholders, as the value is directly tied to the company's common stock performance.
• Participation in the Supplemental Savings Plan indicates a commitment to long-term incentives and retention of key management personnel.

Risks

• The value of the phantom stock units is subject to the market fluctuations of Zoetis common stock.
• Zoetis may limit the timing, frequency, and permissibility of transfers from one investment fund to another for these units.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the nature of the phantom stock units, which are designed to align executive interests with future company performance and are settled upon separation from service.

Industry Context

StockSavvy.ai notes that phantom stock units are a common form of executive compensation in the pharmaceutical and animal health industries, aiming to incentivize long-term performance and retain key talent by linking compensation to stock price appreciation without granting actual equity immediately.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of phantom stock units, particularly through supplemental savings plans, is a standard practice among large-cap companies, including peers in the animal health sector like Elanco Animal Health (ELAN) and IDEXX Laboratories (IDXX).
• These plans are designed to offer deferred compensation and align executive interests with shareholder value over time, similar to long-term incentive plans seen across various industries, ensuring executive retention and performance incentives.

Stakeholder Impact

• Shareholders: The transaction further aligns the Executive Vice President's financial interests with the company's stock performance, potentially encouraging decisions that enhance shareholder value.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The phantom stock units will be settled in cash following Julie Fuller's separation from service.
• Julie Fuller may transfer units into an alternative investment fund at any time, subject to potential limitations by Zoetis regarding timing, frequency, and permissibility of such transfers.

Key Dates

Recommendation

This Form 4 reports a routine executive compensation transaction involving phantom stock units. While it indicates executive alignment, it does not present new material information that would warrant a change in investment recommendation. The transaction is part of a standard long-term incentive plan and does not suggest any immediate catalysts for significant stock price movement.

Keywords

Zoetis, ZTS, Phantom Stock Units, Executive Compensation, Insider Transaction, SEC Form 4, Supplemental Savings Plan, Julie Fuller